Search

everythinglearnresearchcommunity

for

Search:↓

Compound 4 is a promising treatment for hair loss with low toxicity.

Researchers found four key proteins that affect the development of a specific hair type in Yangtze River Delta white goats.

Seeing trauma causes fear in mice by lowering their natural fear-reducing hormones.

Selumetinib causes skin and hair side effects in kids with NF1, affecting treatment and quality of life.

The HPV type 11 region activates hair-specific gene expression in mice.

Antioxidants can benefit skin health but should be used carefully to avoid negative effects.

People with Telogen Effluvium have similar zinc levels in their blood as healthy individuals.

Dutasteride improved both hair loss and acne in two young men.

Certain drugs that block specific enzymes can help treat prostate diseases.

Human skin can produce steroids from cholesterol.

New hair growth corticosterone levels are higher in diabetic mice, indicating long-term stress.

Scientists created cell lines from balding patients and found that cells from the front of the scalp are more affected by hormones that cause hair loss than those from the back.

Testosterone and dihydrotestosterone treatments can help with penile growth in males with 5α-reductase type 2 deficiency, with dihydrotestosterone being more effective in infancy.

Scientists made a carbon-14 labeled version of a drug with a 48% yield and over 99% purity.

A woman was the first known case to have both polycystic ovary syndrome and autoimmune polyglandular syndrome type 2, suggesting a need to check for both conditions in similar patients.

TCHHL1 is a protein important for hair growth, found in hair follicles.

ROXY proteins help plants respond to nitrate shortage by affecting nutrient sensing and growth.

Cyproterone acetate is a safe treatment that causes mild feminizing effects and is more effective with added estrogens.

The bulletin provides guidelines for diagnosing and managing PCOS, suggesting weight loss, hormonal contraceptives, and diabetes screening, with clomiphene for infertility and various treatments for excess hair.

Men generally have more severe COVID-19 cases and higher death rates than women due to biological differences.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

PCOS women with COVID-19 have higher cardiometabolic risks.

The research found that polycystic ovary syndrome (PCOS) has two distinct types, with one having more severe hormone and insulin issues.

Higher levels of miR-1199-5p may reduce the effectiveness of certain prostate treatments.

Child with rickets improved with a specific vitamin D therapy, but alopecia did not change.

Increased 11β-HSD1 activity in skin may contribute to aging and could be targeted to reduce aging effects.

Existing drug dexamethasone may lower death risk in severe COVID-19 cases; more research needed for other drugs.

Cepharanthine effectively reduces Herpes Simplex Virus Type 1 by blocking certain cell pathways and promoting cell death.

Cepharanthine may help treat Equid herpesvirus type 8 by reducing oxidative stress.

Ruxolitinib significantly improves multiple autoimmune conditions in APS-1 patients.